|
Volumn 39, Issue 3, 2002, Pages 377-386
|
Eptifibatide and low-dose tissue plasminogen activator in acute myocardial infarction: The Integrilin and Low-Dose Thrombolysis in Acute Myocardial Infarction (INTRO AMI) trial
h
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
EPTIFIBATIDE;
LOW MOLECULAR WEIGHT HEPARIN;
TISSUE PLASMINOGEN ACTIVATOR;
ACUTE HEART INFARCTION;
ADULT;
AGED;
ANGIOCARDIOGRAPHY;
ARTICLE;
BLEEDING;
BLOOD CLOT LYSIS;
BOLUS INJECTION;
BRAIN HEMORRHAGE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORONARY ARTERY BLOOD FLOW;
CORONARY ARTERY BYPASS GRAFT;
DOSE RESPONSE;
DRUG EFFICACY;
DRUG SAFETY;
ELECTROCARDIOGRAM;
FEMALE;
FIBRINOLYSIS;
HEART MUSCLE PERFUSION;
HEART MUSCLE REVASCULARIZATION;
HEART REINFARCTION;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
ST SEGMENT ELEVATION;
STATISTICAL ANALYSIS;
THROMBOCYTOPENIA;
TREATMENT OUTCOME;
ADULT;
AGED;
CORONARY VESSELS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG THERAPY, COMBINATION;
ELECTROCARDIOGRAPHY;
EUROPE;
FEMALE;
FIBRINOLYTIC AGENTS;
HUMANS;
INCIDENCE;
INTRACRANIAL HEMORRHAGES;
MALE;
MIDDLE AGED;
MYOCARDIAL INFARCTION;
NORTH AMERICA;
PEPTIDES;
PLATELET AGGREGATION INHIBITORS;
PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX;
SOUTH AFRICA;
SURVIVAL ANALYSIS;
THROMBOCYTOPENIA;
TIME FACTORS;
TISSUE PLASMINOGEN ACTIVATOR;
TREATMENT OUTCOME;
VASCULAR PATENCY;
|
EID: 0037028598
PISSN: 07351097
EISSN: None
Source Type: Journal
DOI: 10.1016/S0735-1097(01)01758-2 Document Type: Article |
Times cited : (125)
|
References (21)
|